# Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer

> **NCT00003777** · PHASE2 · TERMINATED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 35 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** amifostine trihydrate
- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **PROCEDURE:** surgical procedure
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003777
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1998-12
- **Primary completion:** 2001-04
- **Final completion:** 2001-04-20
- **Target enrollment:** 35 (ESTIMATED)
- **Why stopped:** PI left institution
- **Last updated:** 2022-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003777, "Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*